| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $19.42B | $34.28B | $35.41B | $5.81B | $37.44B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $11.97B | $11.60B | $10.82B | $9.76B | $10.80B |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | $17.52B | $19.01B | $14.75B | $3.69B | $3.89B |
| Tax Expense | $1.90B | $1.49B | $1.99B | $1.37B | $1.02B |
| Net Income | $4.76B | $4.48B | $5.52B | $5.55B | $5.88B |
| EPS (basic) | 0.0700 | 0.0630 | 0.0760 | 0.0730 | 0.0750 |
| EPS (diluted) | 0.0690 | 0.0620 | 0.0750 | 0.0720 | 0.0750 |
| Shares (diluted) | $60.51B | $63.07B | $65.76B | $69.68B | $71.78B |